Your browser doesn't support javascript.
loading
Revised simulation model does not predict rebound in gonorrhoea prevalence where core groups are treated in the presence of antimicrobial resistance.
Trecker, Molly A; Hogan, Daniel J; Waldner, Cheryl L; Dillon, Jo-Anne R; Osgood, Nathaniel D.
  • Trecker MA; Vaccine and Infectious Disease Organization-International Vaccine Centre, Saskatoon, Saskatchewan, Canada School of Public Health, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Hogan DJ; Department of Computer Science, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Waldner CL; School of Public Health, University of Saskatchewan, Saskatoon, Saskatchewan, Canada Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Dillon JA; Vaccine and Infectious Disease Organization-International Vaccine Centre, Saskatoon, Saskatchewan, Canada Department of Microbiology and Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Osgood ND; Department of Computer Science, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Sex Transm Infect ; 91(4): 300-2, 2015 Jun.
Article en En | MEDLINE | ID: mdl-25512669
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Gonorrea / Modelos Estadísticos / Farmacorresistencia Bacteriana / Antibacterianos / Neisseria gonorrhoeae Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Gonorrea / Modelos Estadísticos / Farmacorresistencia Bacteriana / Antibacterianos / Neisseria gonorrhoeae Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2015 Tipo del documento: Article